Apollo Hospitals begins administering Sputnik V vaccine in Hyderabad
Updated:
Updated:
May 17, 2021 14:31 IST
Marketing partner for Sputnik V in India, Dr. Reddy’s had on May 14 announced the rollout of the vaccine in the country
Share Article
AAA
CEO of Branded Markets (India & Emerging Markets), Dr. Reddy’s Laboratories, M.V. Ramana (left) and president, Hospitals Division, Apollo Hospitals Enterprises Limited, K. Hari Prasad at the launch Sputnik V vaccine programme at Apollo Hospitals, Jubilee Hills in Hyderabad on Monday, May 17, 2021.
| Photo Credit: Nagara Gopal
Marketing partner for Sputnik V in India, Dr. Reddy’s had on May 14 announced the rollout of the vaccine in the country
Moscow [Russia], May 17 (ANI): In a bid to speed up India's COVID-19 vaccination efforts, another Indian company, Shilpa Medicare has joined efforts to ramp up the manufacturing capacity of the Sputnik V vaccine.
Shilpa Medicare to ramp up manufacturing of Sputnik V russiaherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from russiaherald.com Daily Mail and Mail on Sunday newspapers.
Apollo Hospitals begin administering Sputnik V vaccine in Hyderabad thehindu.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindu.com Daily Mail and Mail on Sunday newspapers.
COVID-19: 60,000 doses of Sputnik V vaccine reach India in second batch
COVID-19: 60,000 doses of Sputnik V vaccine reach India in second batch
Updated: May 16, 2021, 15:29 IST
India on Sunday contained 60,000 doses, Dr Reddy s Laboratory informed. Pleased to share that the consignment that arrived today in
Hyderabad contains 60,000 doses of the second dose component of the #SputnikV vaccine. Samples from the consignment will be sent for release to the
Central Drugs Laboratory, the Indian partner of the Russian vaccine manufacturer tweeted.
The second batch of the Sputnik V landed in Hyderabad on Sunday. The first consignment of imported doses of the vaccine landed in India on May 1 and received regulatory clearance from the Central Drugs Laboratory at Kasauli in Himachal Pradesh on May 13.